Methimazole
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Methimazole contains NLT 98.0% and NMT 101.0% of methimazole (C4H6N2S), calculated on the dried basis.
2 IDENTIFICATION
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K
3 ASSAY
Procedure
Sample: 250 mg of Methimazole
Analysis: Dissolve the Sample in 75 mL of water. Add 15.0 mL of 0.1 N sodium hydroxide VS, mix, and add, with stirring, 30 mL of 0.1 N silver nitrate. Continue the titration with 0.1 N sodium hydroxide VS, determining the endpoint potentiometrically. Each milliliter of 0.1 N sodium hydroxide is equivalent to 11.42 mg of methimazole (C4H6N2S).
Acceptance criteria: 98.0%–101.0% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Delete the following:
Selenium 〈291〉
Sample: 200 mg of Methimazole
Acceptance criteria: NMT 30 ppm (USP 1-May-2022)
Change to read:
Organic Impurities
Standard solution: 0.01 mg/mL each of USP Methimazole RS, USP Methimazole Related Compound A RS, 1-methylimidazole, and USP
Methimazole Related Compound C RS in chloroform
Sample solution: 10 mg/mL of Methimazole in chloroform
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: GC
Detector: Flame ionization
Column: 30-m × 0.25-mm; coated with a 0.5-μm
lm of phase G27
Temperatures
Injection port: 150°
Detector: 250°
Column: See Table 1.
Table 1
Initial Temperature (°) | Temperature Ramp (°/min) | Final Temperature (°) | Hold Time at Final Temperature (min) |
| 100 | - | 100 | 2 |
| 100 | 30 | 250 | 15 |
Carrier gas: Helium
Flow rate: 1.5 mL/min
Injection volume: 1 μL
Injection type: Split, split ratio 3:20
System suitability
Sample: Standard solution
Suitability requirements
Resolution: NLT 1.5 between methimazole related compound A and 1-methylimidazole
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of methimazole related compound A, 1-methylimidazole, and methimazole related compound C in the portion of Methimazole taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of each related compound from the Sample solution
rS = peak response of the corresponding related compound from the Standard solution
CS = concentration of the corresponding related compound in the Standard solution (mg/mL)
CU = concentration of Methimazole in the Sample solution (mg/mL)
Calculate the percentage of any other individual impurity in the portion of Methimazole taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of each impurity from the Sample solution
rS = peak response of methimazole from the Standard solution
CS = concentration of USP Methimazole RS in the Standard solution (mg/mL)
CU = concentration of Methimazole in the Sample solution (mg/mL)
Acceptance criteria: See Table 2. The reporting threshold is (USP 1-May-2022) 0.02%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Methimazole related compound A | 0.3 | 0.1 |
| 1-Methylimidazole | 0.4 | 0.1 |
| Methimazole related compound C | 0.7 | 0.1 |
| Methimazole | 1.0 | - |
| Any other individual impurity | - | 0.1 |
| Total impurities | - | 0.5 |
5 SPECIFIC TESTS
Loss on Drying 〈731〉
Analysis: Dry at 105° for 2 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed, light-resistant containers.
USP Reference Standards 〈11〉
USP Methimazole RS
USP Methimazole Related Compound A RS
2,2-Dimethoxy-N-methylethanamine.
C5H13NO2 119.16
USP Methimazole Related Compound C RS
1-Methyl-2-(methylthio)-1H-imidazole.
C5H8N2S 128.20

